Skip to main content

Neurocrine Biosciences Inc

NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000914475

In the last 90 days, Neurocrine Biosciences Inc insiders filed 0 open-market purchases and 7 sales; 782 institutions reported holding it in 13F filings for Q2 2026, worth $17.0B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Neurocrine Biosciences Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
7 filings
6 insiders, $6.24M in total
Insiders trading
6
Net value
−$6.24M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Neurocrine Biosciences Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Neurocrine Biosciences Inc
NameTitleLast reported holdingLast filingFilings, past year
Onyia JudeChief Scientific Officer22,647Sep 15, 20269
Lippoldt DarinChief Legal Officer56,793Sep 15, 20267
Keswani Sanjay ChandruChief Medical Officer3,281Sep 15, 20263
Gorman Kevin CharlesDirector517,797Sep 15, 20265
Gano KyleChief Executive Officer154,728Sep 15, 20265
Delaet IngridChief Regulatory Officer18,289Sep 15, 20266
Cooke JulieChief Human Resources Officer24,025Sep 15, 20264
Boyer David W.Chief Corp. Affairs Officer8,722Sep 15, 20264
Benevich EricChief Commercial Officer67,297Sep 15, 20265
Abernethy MattChief Financial Officer42,808Sep 15, 20264
Sherwin Stephen ADirector14,860Sep 3, 20264
Norwalk Leslie VDirector2,430Jul 30, 20266
Morrow George JDirector10,386May 29, 20263
Lyons Gary ADirector122,141May 29, 20263
Pops Richard FDirector37,798May 29, 20263
Poon Christine ADirector4,753May 29, 20262
Rastetter William HDirector43,678May 29, 20263
Sharp ShaliniDirector4,088May 29, 20262
Mercier JohannaDirector6,853May 29, 20262
Roberts EiryChief Medical Officer35,640Feb 14, 20250
Lloyd-Smith MalcolmChief Integration Officer42,337Feb 8, 20230
Grigoriadis Dimitri E.Chief Research Officer82,273Feb 2, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 29, 2021 (view filing)Jul 272 daysLloyd-Smith MalcolmChief Regulatory OfficerSSale−16.7K$93.80−$1.57M−51.4%15.8K after
Aug 18, 2021 (view filing)Aug 162 daysBenevich EricChief Commercial OfficerSSale−5.63K$89.62−$504.4K−26.5%15.6K after
Oct 6, 2021 (view filing)Oct 42 daysCooke JulieChief Human Resources OfficerSSale−987$101.73−$100.4K−6.2%14.8K after
Oct 12, 2021 (view filing)Oct 75 daysGrigoriadis Dimitri E.Chief Research OfficerSSale−8.00K$104.81−$838.5K−8.9%82.3K after2 lots
Oct 12, 2021 (view filing)Oct 75 daysLyons Gary ADirectorSSale−5.00K$105.06−$525.3K−2.3%208.7K after
Dec 3, 2021 (view filing)Dec 12 daysAbernethy MattChief Financial OfficerSSale−1.65K$82.59−$135.9K−9.1%16.3K after
Jan 7, 2022 (view filing)Jan 52 daysGano KyleChief Business Development OffSSale−28.3K$85.50−$2.42M−21.2%105.0K after
Jan 12, 2022 (view filing)Jan 102 daysRoberts EiryChief Medical OfficerSSale−2.63K$74.50−$196.1K−11.0%21.3K after
Jan 26, 2022 (view filing)Jan 242 daysSherwin Stephen ADirectorSSale−15.0K$74.43−$1.12M−37.4%25.1K after
Feb 9, 2022 (view filing)Feb 7-82 daysAbernethy MattChief Financial OfficerSSale−4.29K$80.53−$345.5K−17.5%20.2K after3 lots
Feb 9, 2022 (view filing)Feb 7-82 daysBenevich EricChief Commercial OfficerSSale−5.10K$80.57−$410.8K−20.0%20.3K after4 lots
Feb 9, 2022 (view filing)Feb 7-82 daysCooke JulieChief Human Resources OfficerSSale−2.86K$80.38−$229.7K−14.1%17.4K after4 lots
Feb 9, 2022 (view filing)Feb 7-82 daysGano KyleChief Business Development OffSSale−6.88K$80.62−$554.6K−5.8%111.2K after5 lots
Feb 9, 2022 (view filing)Feb 7-82 daysGorman Kevin CharlesChief Executive OfficerSSale−11.0K$80.54−$884.7K−2.3%462.8K after4 lots
Feb 9, 2022 (view filing)Feb 7-82 daysLippoldt DarinChief Legal OfficerSSale−4.08K$80.45−$328.2K−9.7%38.1K after4 lots
Feb 9, 2022 (view filing)Feb 7-82 daysLloyd-Smith MalcolmChief Regulatory OfficerSSale−3.38K$80.48−$272.2K−15.3%18.7K after4 lots
Feb 9, 2022 (view filing)Feb 7-82 daysRoberts EiryChief Medical OfficerSSale−3.72K$80.45−$299.6K−13.1%24.6K after3 lots
Feb 9, 2022 (view filing)Feb 7-82 daysBoyer David W.Chief Corp. Affairs OfficerSSale−940$79.99−$75.2K−24.4%2.92K after2 lots
Mar 22, 2022 (view filing)Mar 18-224 daysLippoldt DarinChief Legal OfficerSSale−8.76K$95.05−$832.1K−22.9%29.4K after2 lots
Apr 5, 2022 (view filing)Apr 14 daysRastetter William HDirectorSSale−10.7K$94.93−$1.02M−24.0%34.0K after
Apr 27, 2022 (view filing)Apr 252 daysLyons Gary ADirectorSSale−15.0K$92.76−$1.39M−6.7%208.7K after
May 11, 2022 (view filing)May 92 daysPops Richard FDirectorSSale−15.0K$76.30−$1.14M−33.7%29.5K after2 lots
Jun 29, 2022 (view filing)Jun 272 daysCooke JulieChief Human Resources OfficerSSale−754$100.00−$75.4K−4.3%16.9K after
Aug 9, 2022 (view filing)Aug 54 daysCooke JulieChief Human Resources OfficerSSale−1.82K$100.00−$181.6K−10.7%15.1K after
Aug 16, 2022 (view filing)Aug 124 daysLloyd-Smith MalcolmChief Regulatory OfficerSSale−21.5K$105.95−$2.28M−53.3%18.9K after
Oct 5, 2022 (view filing)Oct 41 dayLippoldt DarinChief Legal OfficerSSale−10.0K$111.04−$1.11M−25.5%29.2K after
Oct 5, 2022 (view filing)Oct 41 dayLyons Gary ADirectorSSale−5.00K$110.54−$552.7K−2.4%203.7K after
Oct 5, 2022 (view filing)Oct 32 daysBoyer David W.Chief Corp. Affairs OfficerSSale−1.44K$106.59−$153.2K−25.4%4.21K after
Oct 19, 2022 (view filing)Oct 172 daysBenevich EricChief Commercial OfficerSSale−4.96K$110.82−$549.7K−24.1%15.6K after
Oct 28, 2022 (view filing)Oct 26-272 daysLippoldt DarinChief Legal OfficerSSale−10.0K$115.03−$1.15M−25.5%29.2K after2 lots
Nov 2, 2022 (view filing)Oct 312 daysBoyer David W.Chief Corp. Affairs OfficerSSale−1.29K$114.12−$147.8K−30.7%2.92K after
Nov 2, 2022 (view filing)Nov 1-21 dayLippoldt DarinChief Legal OfficerSSale−10.4K$120.28−$1.25M−26.2%29.2K after2 lots
Nov 2, 2022 (view filing)Oct 312 daysLyons Gary ADirectorSSale−15.0K$114.76−$1.72M−6.9%203.7K after
Nov 4, 2022 (view filing)Nov 2-32 daysBenevich EricChief Commercial OfficerSSale−9.37K$125.02−$1.17M−37.5%15.6K after2 lots
Nov 4, 2022 (view filing)Nov 2-32 daysCooke JulieChief Human Resources OfficerSSale−8.41K$125.00−$1.05M−35.8%15.1K after2 lots
Nov 4, 2022 (view filing)Nov 31 dayLippoldt DarinChief Legal OfficerSSale−4.52K$125.02−$564.8K−13.4%29.2K after
Nov 10, 2022 (view filing)Nov 82 daysCooke JulieChief Human Resources OfficerSSale−5.59K$124.99−$698.9K−27.0%15.1K after
Nov 10, 2022 (view filing)Nov 82 daysLippoldt DarinChief Legal OfficerSSale−5.08K$125.04−$635.5K−14.8%29.2K after
Nov 10, 2022 (view filing)Nov 8-102 daysBenevich EricChief Commercial OfficerSSale−24.7K$125.33−$3.09M−61.2%15.6K after2 lots
Dec 1, 2022 (view filing)Nov 292 daysOnyia JudeChief Scientific OfficerSSale−2.33K$121.90−$284.1K−49.6%2.37K after
Dec 1, 2022 (view filing)Nov 301 dayBenevich EricChief Commercial OfficerSSale−50.0K$125.90−$6.29M−76.2%15.6K after3 lots
Jan 5, 2023 (view filing)Jan 32 daysPops Richard FDirectorSSale−15.0K$119.20−$1.79M−33.7%29.5K after
Jan 5, 2023 (view filing)Jan 32 daysSherwin Stephen ADirectorSSale−30.0K$118.86−$3.57M−54.5%25.1K after2 lots
Jan 10, 2023 (view filing)Jan 64 daysBenevich EricChief Commercial OfficerSSale−400$125.00−$50.0K−2.5%15.6K after
Feb 2, 2023 (view filing)Jan 312 daysAbernethy MattChief Financial OfficerSSale−1.28K$109.98−$141.1K−5.7%21.4K after
Feb 2, 2023 (view filing)Jan 312 daysBenevich EricChief Commercial OfficerSSale−1.21K$109.95−$132.7K−6.7%16.7K after
Feb 2, 2023 (view filing)Jan 312 daysBoyer David W.Chief Corp. Affairs OfficerSSale−1.10K$109.92−$121.4K−22.0%3.91K after
Feb 2, 2023 (view filing)Jan 312 daysCooke JulieChief Human Resources OfficerSSale−916$108.48−$99.4K−5.4%15.9K after
Feb 2, 2023 (view filing)Jan 312 daysGano KyleChief Business Development OffSSale−1.54K$109.98−$169.5K−1.3%112.8K after
Feb 2, 2023 (view filing)Jan 312 daysGorman Kevin CharlesChief Executive OfficerSSale−2.71K$110.08−$298.0K−0.6%465.3K after